ESSA Pharma (EPIX) News Today $1.54 +0.00 (+0.33%) As of 03/27/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period ESSA Pharma (NASDAQ:EPIX) Stock Price Passes Below 50 Day Moving Average - Here's WhyESSA Pharma (NASDAQ:EPIX) Stock Price Passes Below Fifty Day Moving Average - What's Next?March 26 at 4:03 AM | marketbeat.comESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIXMarch 25 at 12:52 PM | prnewswire.comEPIX Deadline Today: Rosen Law Firm Urges ESSA Pharma Inc. (NASDAQ: EPIX) Stockholders with Large Losses to Contact the Firm for Information About Their RightsMarch 25 at 11:18 AM | businesswire.comESSA Pharma Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; March 25, 2025 Deadline to file Lead Plaintiff MotionMarch 24, 2025 | globenewswire.comFINAL REMINDER EPIX DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts ESSA Pharma Inc. Investors to Participate in the Class Action Lawsuit!March 24, 2025 | markets.businessinsider.comThe Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIXMarch 24, 2025 | prnewswire.comESSA Pharma Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights – EPIXMarch 24, 2025 | globenewswire.comEPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ESSA Pharma Inc. ...March 23, 2025 | gurufocus.comEPIX IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages ESSA Pharma Inc. ...March 23, 2025 | gurufocus.comEPIX IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - EPIXMarch 23, 2025 | globenewswire.comSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA PharmaMarch 23, 2025 | globenewswire.comEPIX DEADLINE TUESDAY: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - EPIXMarch 22, 2025 | investing.comEPIX DEADLINE ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - EPIXMarch 22, 2025 | investing.comLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in ESSA Pharma Inc. Lawsuit – EPIXMarch 21, 2025 | globenewswire.comFaruqi & Faruqi Reminds ESSA Pharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIXMarch 21, 2025 | prnewswire.comLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in ESSA Pharma Inc. Lawsuit - EPIXMarch 21, 2025 | prnewswire.comEPIX DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 25 Deadline in Securities Class Action - EPMarch 20, 2025 | investing.comEPIX DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 25 Deadline in Securities Class Action - EPIXMarch 20, 2025 | globenewswire.comThe Gross Law Firm Reminds ESSA Pharma Inc. ...March 20, 2025 | gurufocus.comThe Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 – EPIXMarch 20, 2025 | globenewswire.comThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in ESSA Pharma Inc. Lawsuit - EPIXMarch 20, 2025 | prnewswire.comEPIX DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 25 Deadline in Securities Class Action - EPMarch 19, 2025 | investing.comESSA Pharma Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. ...March 19, 2025 | gurufocus.comESSA Pharma Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. March 25, 2025 Deadline to file Lead Plaintiff Motion.March 19, 2025 | globenewswire.comEPIX Investors Have Final Opportunity Approaching to Lead ESSA Pharma Inc. ...March 19, 2025 | gurufocus.comEPIX Investors Have Final Opportunity Approaching to Lead ESSA Pharma Inc. Securities Fraud Lawsuit with the Schall Law FirmMarch 19, 2025 | prnewswire.comLevi & Korsinsky Notifies Shareholders of ESSA Pharma Inc. ...March 18, 2025 | gurufocus.comEPIX Deadline: EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud LawsuitMarch 18, 2025 | gurufocus.comEPIX Deadline: EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud LawsuitMarch 18, 2025 | prnewswire.comLevi & Korsinsky Notifies Shareholders of ESSA Pharma Inc.(EPIX) of a Class Action Lawsuit and an Upcoming DeadlineMarch 18, 2025 | globenewswire.comInvestors in ESSA Pharma Inc. Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights - EPIXMarch 18, 2025 | prnewswire.comESSA Pharma (NASDAQ:EPIX) Stock Price Passes Below Fifty Day Moving Average - What's Next?ESSA Pharma (NASDAQ:EPIX) Share Price Crosses Below Fifty Day Moving Average - Here's What HappenedMarch 18, 2025 | marketbeat.comEPIX DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - EPIXMarch 17, 2025 | globenewswire.comEPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ESSA Pharma Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitMarch 17, 2025 | globenewswire.comThe Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 – EPIXMarch 17, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against ESSA Pharma Inc. and Certain Officers - EPIXMarch 17, 2025 | prnewswire.comESSA Pharma Inc. Class Action: The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIXMarch 17, 2025 | prnewswire.comEPIX IMPORTANT DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - EPIXMarch 16, 2025 | investing.comEPIX FINAL DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - EPIXMarch 15, 2025 | investing.comINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA PharmaMarch 15, 2025 | globenewswire.comEPIX FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - EPIXMarch 14, 2025 | globenewswire.comEPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit with the Schall Law FirmMarch 14, 2025 | prnewswire.comEPIX Deadline: EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud LawsuitMarch 13, 2025 | gurufocus.comEPIX Deadline: EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud LawsuitMarch 13, 2025 | prnewswire.comESSA Pharma Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. March 25, 2025 Deadline to file Lead Plaintiff MotionMarch 13, 2025 | globenewswire.comEPIX LAWSUIT ALERT: Levi & Korsinsky Notifies ESSA Pharma Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineMarch 13, 2025 | globenewswire.comMarch 25, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against EPIXMarch 13, 2025 | prnewswire.comLevi & Korsinsky Notifies ESSA Pharma Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - EPIXMarch 12, 2025 | prnewswire.comROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIXMarch 11, 2025 | globenewswire.comROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIXMarch 11, 2025 | investing.com Remove Ads Get ESSA Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for EPIX and its competitors with MarketBeat's FREE daily newsletter. Email Address EPIX Media Mentions By Week EPIX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EPIX News Sentiment▼0.160.78▲Average Medical News Sentiment EPIX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EPIX Articles This Week▼164▲EPIX Articles Average Week Remove Ads Get ESSA Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for EPIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Atea Pharmaceuticals News Corvus Pharmaceuticals News MBX Biosciences News Immutep News Prime Medicine News Acelyrin News iTeos Therapeutics News Cidara Therapeutics News Aurora Cannabis News 2seventy bio News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EPIX) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ESSA Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ESSA Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
